Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 5/2/16)$47.22
Total Net Assets (As of 3/31/16)$3.79B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 0.95%
NET 0.95%

Performance (As of 3/31/16)
1 Year-17.28%
3 Year19.68%
5 Year19.69%
10 Year11.29%
Morningstar (As of 3/31/16)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

124 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Data as of 3/31/16. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Allergan plc 3.79
Amgen Inc 3.76
AbbVie Inc 3.19
Celgene Corp 3.09
Bristol-Myers Squibb Co 2.72
Boston Scientific Corp 2.71
Aetna Inc 2.67
Teva Pharmaceutical Industries Ltd (ADR) 2.49
Sanofi 2.46
Universal Health Services Inc 2.38
TOTAL29.26

CHARACTERISTICS

Number of Holdings
Equity Issues

93
Market Capitalization
Weighted Average
Median

$49.63B
$31.12B
Portfolio Turnover Ratio
(1-year trailing)

46.44%
Price/Earnings Ratio
(1-year forward)

16.98
Price/Book Ratio
(1-year forward)

4.34
Earnings Growth Rate
(1-year forward)

8.39%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
GW Pharmaceuticals PLC (ADR)
Alder Biopharmaceuticals Inc
Universal Health Services Inc
Boston Scientific Corp
HCA Holdings Inc
DETRACTORS
Valeant Pharmaceuticals International Inc
Endo International PLC
Actavis PLC
Diplomat Pharmacy Inc
Puma Biotechnology Inc

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 98.73 100.00
 
 
US Industrials 0.27 -
 
Cash & Equivalents 0.95 -
 
Restricted Cash 0.05 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 78.07 66.15
Non-U.S. Developed 20.93 33.85
Restricted Cash 0.05 -
Cash & Equivalents 0.95 -

REGIONS (%)

FUNDINDEX
North America 78.07 66.37
Europe 17.64 25.31
Africa/Mideast 2.49 1.26
Japan 0.80 5.61
Cash & Equivalents 0.95 -
Restricted Cash 0.05 -

COUNTRIES (%)

FUNDINDEX
United States 78.07 66.16
United Kingdom 5.95 5.48
Switzerland 4.27 9.27
France 3.86 2.96
Israel 2.49 1.26
Denmark 2.47 3.07
Germany 1.05 3.94
Japan 0.80 5.62
Netherlands 0.04 -
Cash & Equivalents 0.95 -
Restricted Cash 0.05 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 21.32 45.68
$50 Billion to $100 Billion 16.19 18.13
$10 Billion to $50 Billion 27.56 30.49
$5 Billion to $10 Billion 11.23 4.69
$1 Billion to $5 Billion 13.74 1.01
$500 Million to $1 Billion 4.80 -
$250 Million to $500 Million 1.81 -
$100 Million to $250 Million 0.40 -
N/A 1.68 -

TOP INDUSTRIES (%)

FUNDINDEX
Biotechnology 34.44 17.22
Pharmaceuticals 34.02 51.45
Health Care Equipment 9.49 11.43
Managed Health Care 4.62 6.67
Health Care Facilities 4.39 1.33
Health Care Services 4.37 3.59
Health Care Distributors 2.38 2.62
Health Care Technology 2.32 0.63
Health Care Supplies 1.36 1.77
Life Sciences Tools & Services 1.34 3.29

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.